Abstract: An automated carousel and system configured for translationally moving a plurality of biological production units in unison along a vertical frame while maintaining a precise alignment of each of the biological production units relative to gravity, and simultaneously providing independent dynamic adjustment of the axial orientation of each of the plurality of biological production units relative to gravity. The automated carousel may be adapted for use with a variety of biological production units supporting cell culture and/or tissue engineering systems in various clinical and laboratory settings and provides for ergonomic use thereof.

Abstract: An automated carousel and system configured for translationally moving a plurality of biological production units in unison along a vertical frame while maintaining a precise alignment of each of the biological production units relative to gravity, and simultaneously providing independent dynamic adjustment of the axial orientation of each of the plurality of biological production units relative to gravity. The automated carousel may be adapted for use with a variety of biological production units supporting cell culture and/or tissue engineering systems in various clinical and laboratory settings and provides for ergonomic use thereof.

Abstract: An automated cell culture and tissue engineering system comprising defined and separate environmental zones provide for increased control and maintenance of the internal environment of the system such that the temperature, air flow and gases surrounding the bioreactor module form one zone that is maintained separately to a second zone formed surrounding the reagent fluid reservoir. The system further comprises means for elimination and/or management of condensation within the second zone of the system.

Abstract: An automated cell culture and tissue engineering system comprising defined and separate environmental zones provide for increased control and maintenance of the internal environment of the system such that the temperature, air flow and gases surrounding the bioreactor module form one zone that is maintained separately to a second zone formed surrounding the reagent fluid reservoir. The system further comprises means for elimination and/or management of condensation within the second zone of the system.

Abstract: Systems and methods for process control of automated cell engineering systems are provided. Automated cell engineering systems provide automated cell processing functionality. Automated process control systems provide control, interconnectivity, monitoring, data archival, software updating, and other oversight functions for automated cell engineering systems. Further, central control process systems provide control, monitoring, data archival, software updating, and other oversight functions for automated process control systems.

Abstract: An automated cell culture and tissue engineering system comprising defined and separate environmental zones provide for increased control and maintenance of the internal environment of the system such that the temperature, air flow and gases surrounding the bioreactor module form one zone that is maintained separately to a second zone formed surrounding the reagent fluid reservoir. The system further comprises means for elimination and/or management of condensation within the second zone of the system.

Abstract: An automated carousel and system configured for translationally moving a plurality of biological production units in unison along a vertical frame while maintaining a precise alignment of each of the biological production units relative to gravity, and simultaneously providing independent dynamic adjustment of the axial orientation of each of the plurality of biological production units relative to gravity. The automated carousel may be adapted for use with a variety of biological production units supporting cell culture and/or tissue engineering systems in various clinical and laboratory settings and provides for ergonomic use thereof.

Abstract: The present disclosure provides cell therapy production systems that can suitably be used in a patient bedside setting. Such systems allow for direct removal of a patient's blood, automated processing to produce a cell therapy, and then infusion back into the patient, without the need to remove the system from the patient's bedside. Also provided herein are systems for production of cell therapies in a bedside setting.

Abstract: A system includes a channel over which to charge a battery, control circuitry, and a discharge circuit associated with the channel to discharge the battery. The discharge circuit is configured for discharging the battery at a current that exceeds an operational current through the channel. In response to a fault in the battery, the control circuitry is configured to disconnect the battery from a signal path in the channel and to produce an electrical connection to enable discharge of the battery through the discharge circuit.

Abstract: A method is described for retrieving, by a test system, a formation profile associated with the storage cell, the formation profile comprising one or more formation segments, with a formation segment comprising an action to be performed upon a detection of a signature value; measuring, by the test system, a value of a parameter of the formation segment; detecting, based on a comparison between the value of the parameter and one or more signatures associated with the formation segment, that the value of the parameter comprises the signature value; and performing the action specified in the formation segment.

Abstract: This invention relates to a method of anodising magnesium material which includes anodising the magnesium while it is immersed in an aqueous electrolyte solution having a pH above 7, and in the presence of a phosphate, the electrolyte solution also containing a sequestering agent. The method may further include the provision of a plasma suppressing substance within the electrolyte solution. Furthermore, the electrolyte solution may also preferably include a tertiary amine such a TEA, and the current passed through the electrolyte solution may preferably be a straight DC current.

Abstract: A sealing gasket for a waveguide assembly having a primary sealing surface loop defining a first plane and at least one secondary loop defining a second plane. The primary sealing surface loop intersecting with and being broken by the at least one secondary loop at two locations around the secondary loop.

Abstract: A sealing gasket and corresponding sealing groove pair formed in mating sealing surface(s). The sealing gasket has a cross section with a plurality of lobes in a generally H-shaped configuration. The sealing groove(s) are formed with a groove bottom between opposing groove side(s); the groove bottom having a middle ridge projecting towards an open end of the groove(s). The sealing gasket compresses and seals against the sealing groove(s) as the sealing surface(s) are mated against each another. Each groove side may also have a recess shoulder at the sealing surface.

Abstract: A sealing gasket for a waveguide assembly having a primary sealing surface loop defining a first plane and at least one secondary loop defining a second plane. The primary sealing surface loop intersecting with and being broken by the at least one secondary loop at two locations around the secondary loop.

Abstract: This invention relates to a method of anodising magnesium material which includes anodising the magnesium while it is immersed in an aqueous electrolyte solution having a pH above 7, and in the presence of a phosphate, the electrolyte solution also containing a sequestering agent. The method may further include the provision of a plasma suppressing substance within the electrolyte solution. Furthermore, the electrolyte solution may also preferably include a tertiary amine such a TEA, and the current passed through the electrolyte solution may preferably be a straight DC current.

Abstract: Provided is, among other things, a method of adhering cells to a target surface which is a tissue surface of a mammal or such a tissue surface coated with a biodegradable polymer sheet, comprising: coating the target surface with a mixture of a first component comprising a non-polymeric fibrin-related protein and a second component effective for converting the fibrin-related protein to fibrin polymer; and spraying a suspension of the cells onto the coated target surface, wherein the mixed two components have formed a fibrin polymer with a tack effective to adhere the cells.

Abstract: The invention is a Brassica plant comprising a homozygous fertility restorer gene for ogura cytoplasmic male sterility, in addition to oilseed, meal and oil produced from the plant, and the use of oilseed of the plant for preparing oil and/or meal. Upon pollination, the plant yields oilseeds having a total glucosinolate content of not more than 30 &mgr;mol/gram, not more than 25 &mgr;mol/gram or not more than 20 &mgr;mol/gram and, optionally, an erucic acid content of no more than two percent by weight based upon the total fatty acid content. The Brassica plant may be Brassica napus, Brassica campestris, or Brassica juncea.

Abstract: The invention is a Brassica plant comprising a homozygous fertility restorer gene for ogura cytoplasmic male sterility, in addition to oilseed, meal and oil produced from the plant, and the use of oilseed of the plant for preparing oil and/or meal. Upon pollination, the plant yields oilseeds having a total glucosinolate content of not more than 30¼ mol/gram, not more than 25¼ mol/gram or not more than 20¼ mol/gram and, optionally, an erucic acid content of no more than two percent by weight based upon the total fatty acid content. The Brassica plant may be Brassica napus. Brassica campestris, or Brassica juncea.

Abstract: An improved Brassica oilseed, an improved plant capable of forming the same, and an improved edible endogenous vegetable oil derived from oilseed Brassica are provided. The edible endogenous vegetable oil of the present invention possesses an improved distribution of fatty acids following crushing and extraction in the absence of hydrogenation or other chemical or physical modification. The alpha-linolenic acid content is less than 3.5 percent by weight, the oleic acid content is at least 77 percent by weight, the total saturated fatty acid content is no more than 4.5 percent by weight, and the erucic acid content is no more than 2 percent by weight based upon the total fatty acid content. Each of the recited characteristics of the oil is controlled by genetic means and surprisingly is simultaneously expressed (e.g., in the field under conventional oilseed Brassica growing conditions) in the absence of cancellation as the result of the formation of the other recited traits.

Abstract: An improved Brassica oilseed, an improved plant capable of forming the same, and an improved edible endogenous vegetable oil derived from oilseed Brassica are provided. The edible endogenous vegetable oil of the present invention possesses an improved distribution of fatty acids following crushing and extraction in the absence of hydrogenation or other chemical or physical modification. The alpha-linolenic acid content is less than 3.5 percent by weight, the oleic acid content is at least 77 percent by weight, the total saturated fatty acid content is no more than 4.5 percent by weight, and the erucic acid content is no more than 2 percent by weight based upon the total fatty acid content. Each of the recited characteristics of the oil is controlled by genetic means and surprisingly is simultaneously expressed (e.g., in the field under conventional oilseed Brassica growing conditions) in the absence of cancellation as the result of the formation of the other recited traits.